Tagged with P

Malaysia Lim Teng Chyuan, president of the Malaysian Association for Pharmaceutical Suppliers (MAPS), discusses the association’s role in solving and supporting its members with the numerous regulatory issues and compliance requirements in Malaysia. He also details his position as managing director at Somedico, a local importer and distributor, and the diverse…

Algeria Professor Kamel Bouzid, president of the Algerian Society of Medical Oncology, provides an insight into the efforts to fight against cancer in Algeria. Could you please give us an overview of the cancer prevalence in Algeria? In Algeria, 75 percent of cancers are metastasized cancers, and only 25 percent are…

Hong Kong Professor Anne W.M. Lee, vice chairman of the Hong Kong Anti-Cancer Society, discusses the role of patient associations in driving change within healthcare systems. Professor Lee, could you perhaps start by sharing the current strategic priorities of the Hong Kong Anti-Cancer Society (HKACS)? As the biggest non-government organization (NGO) in…

Algeria Prof. Messaoud Zitouni, head of the Algerian National Cancer Plan, highlights the Plan’s main advancements since 2015 as well as the gaps to still address. Three years after the launch of the Cancer Plan, what is the current status on achievements? Initially laid out as a five-year plan, two now…

Regulation It has been reported that in 2017 around 72,000 Americans died from drug overdoses, many from opiates. The company receiving the most attention is Purdue Pharma, run by the Sackler Family. Last week, the Financial Times launched multiple reports on the Sackler family and revealed a shocking story of manipulative sales tactics.  The…

Turkey Dr. Hakkı Gürsöz, president of the Turkish Medicines and Medical Devices Agency (TiTCK), provides insights into recent localization and pricing policies and delivers strong messages to both domestic and foreign companies operating in Turkey while underlining TiTCK’s ambitions to work hand-in-hand with the industry, the world’s most respected regulatory authorities…

Cannabis Founded in 1998, GW Pharmaceuticals is a true pioneer in cannabinoid medicines and the only pharmaceutical company with a license to cultivate cannabis in the UK. “While people were wary of cannabis, they became very aware that it was treating patients with severe conditions, where other medicines had either failed…

Japan It is said that ostriches have the strongest immune system of any animal in the world. Because of this, they have shown great promise in preventative healthcare in humans and the beauty industry. The antibodies are resistant to higher pH levels and can remain active even when exposed to heat…

Cancer Novartis receives NHS approval for their CAR T-cell therapy to treat leukaemia in children, 10 days after receiving European Commission (EC) approval. “It’s fantastic news for children and young people with this form of leukaemia.” Prof Charles Swanton, Cancer Research UK’s Dubbed as the future of cancer therapy, Kymriah, Novartis’ gene-modifying treatment…

Spain Dr Carlos Macaya received worldwide recognition as a cardiovascular surgeon after he operated on the tender heart of Mother Teresa. Now, as the President of the Spanish Heart Foundation, he wages the war on heart disease in Spain. Spanish women die five per cent more than men from cardiovascular diseases.…

Hong Kong Dr. Daniel Thurley, general manager of Roche Hong Kong and Macau, shares his first impressions of the affiliate, the strategic significance of Hong Kong to Roche globally, the innovative medicines and technology Roche is committed to bringing to Hong Kong, and his insights on Roche’s commitment to patient-centricity. There have…

Turkey Dr. Erdal Bozdoğan, the recently appointed general manager of Takeda Turkey, leverages his 20 years of experience in the pharmaceutical industry and his expertise of emerging markets to document Turkey’s attractiveness for Takeda and how, as a doctor, his patient orientated mindset is “no longer a dream but a reality”,…